Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

NeuroPace (NPCE) EBIAT (2020 - 2025)

NeuroPace has reported EBIAT over the past 6 years, most recently at -$2.7 million for Q4 2025.

  • Quarterly results put EBIAT at -$2.7 million for Q4 2025, up 48.02% from a year ago — trailing twelve months through Dec 2025 was -$21.5 million (up 20.91% YoY), and the annual figure for FY2025 was -$21.5 million, up 20.91%.
  • EBIAT for Q4 2025 was -$2.7 million at NeuroPace, up from -$3.5 million in the prior quarter.
  • Over the last five years, EBIAT for NPCE hit a ceiling of -$2.7 million in Q4 2025 and a floor of -$12.7 million in Q2 2022.
  • Median EBIAT over the past 5 years was -$8.6 million (2021), compared with a mean of -$8.2 million.
  • Biggest five-year swings in EBIAT: plummeted 131.55% in 2021 and later soared 48.02% in 2025.
  • NeuroPace's EBIAT stood at -$10.7 million in 2021, then decreased by 4.24% to -$11.1 million in 2022, then surged by 44.37% to -$6.2 million in 2023, then increased by 15.32% to -$5.2 million in 2024, then soared by 48.02% to -$2.7 million in 2025.
  • The last three reported values for EBIAT were -$2.7 million (Q4 2025), -$3.5 million (Q3 2025), and -$8.7 million (Q2 2025) per Business Quant data.